Previous Close | 7.75 |
Open | 7.82 |
Bid | 7.73 x 200 |
Ask | 7.79 x 200 |
Day's Range | 7.55 - 7.92 |
52 Week Range | 2.65 - 13.70 |
Volume | |
Avg. Volume | 625,866 |
Market Cap | 481.69M |
Beta (5Y Monthly) | 2.28 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Investors who take an interest in Fulcrum Therapeutics, Inc. ( NASDAQ:FULC ) should definitely note that the CEO...
Fulcrum Therapeutics ( NASDAQ:FULC ) Full Year 2023 Results Key Financial Results Net loss: US$97.3m (loss narrowed by...
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2023 Earnings Call Transcript February 27, 2024 Fulcrum Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.4, expectations were $-0.44. FULC isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to Fulcrum […]